IBDEI3AF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,55247,0)
 ;;=A69.20^^256^2777^50
 ;;^UTILITY(U,$J,358.3,55247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55247,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,55247,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,55247,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,55248,0)
 ;;=A69.22^^256^2777^52
 ;;^UTILITY(U,$J,358.3,55248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55248,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,55248,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,55248,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,55249,0)
 ;;=A69.21^^256^2777^51
 ;;^UTILITY(U,$J,358.3,55249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55249,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,55249,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,55249,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,55250,0)
 ;;=A69.29^^256^2777^18
 ;;^UTILITY(U,$J,358.3,55250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55250,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,55250,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,55250,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,55251,0)
 ;;=A69.23^^256^2777^5
 ;;^UTILITY(U,$J,358.3,55251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55251,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,55251,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,55251,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,55252,0)
 ;;=A51.0^^256^2777^29
 ;;^UTILITY(U,$J,358.3,55252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55252,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,55252,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,55252,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,55253,0)
 ;;=A52.3^^256^2777^54
 ;;^UTILITY(U,$J,358.3,55253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55253,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,55253,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,55253,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,55254,0)
 ;;=A52.10^^256^2777^53
 ;;^UTILITY(U,$J,358.3,55254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55254,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,55254,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,55254,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,55255,0)
 ;;=A52.9^^256^2777^49
 ;;^UTILITY(U,$J,358.3,55255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55255,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,55255,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,55255,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,55256,0)
 ;;=A53.9^^256^2777^79
 ;;^UTILITY(U,$J,358.3,55256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55256,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,55256,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,55256,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,55257,0)
 ;;=B37.3^^256^2777^17
 ;;^UTILITY(U,$J,358.3,55257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55257,1,3,0)
 ;;=3^Candidiasis Vulva/Vagina
 ;;^UTILITY(U,$J,358.3,55257,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,55257,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,55258,0)
 ;;=B58.9^^256^2777^82
 ;;^UTILITY(U,$J,358.3,55258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55258,1,3,0)
 ;;=3^Toxoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,55258,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,55258,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,55259,0)
 ;;=A59.01^^256^2777^83
 ;;^UTILITY(U,$J,358.3,55259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55259,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,55259,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,55259,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,55260,0)
 ;;=B59.^^256^2777^66
 ;;^UTILITY(U,$J,358.3,55260,1,0)
 ;;=^358.31IA^4^2
